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Cerebral venous thrombosis (CVT) should be considered in the diﬀerential diagnosis of all unexplained CNS disorders of sudden
onset. Etiological factors are often subclinical forms of several common thrombophilic states occurring together, rather than
the typical inherited and rare causes. Diagnosis is missed because of the heterogeneity in clinical presentation and etiological
factors. In several patients with the so called idiopathic CVT nutritional deﬁciencies and lifestyle issues are more important
factors in pathogenesis, rather than single rarer causes. High index of suspicion is the key to diagnosis. Clinical skill has to be
ﬁne tuned to diagnose the problem and to identify all the etiological factors. Radiology is essential for diagnosis but relying on
radiology alone will lead to missing several cases and even erroneous diagnosis. It is inappropriate to proceed prematurely to
laboratory investigations, forgetting proper clinical evaluation by studying diet, lifestyle, and environment of the patients. Success




Thrombosis of the cranial venus sinuses and the cerebral
cortical veins can lead to a distinct cerebrovascular disorder,
which unlike arterial stroke, most often aﬀects even young
adults and children. Symptoms and clinical course are highly
variable, etiological factors are even more heterogeneous
making cerebral cortical vein thrombosis (CVT) a unique
clinical entity. The disorder can occur de novo as the ﬁrst
manifestation or can overlap on another existing clinical
problem. In either case it is always multifactorial and is
variable in each patient. Each component of the Virchow’s
triad (endothelial damage, stasis and hypercoagulability of
blood) may in turn have several contributory factors/causes
to produce the ﬁnal manifestation of CVT [1]. These fac-
tors, which vary from patient to patient, operate together in-
cidentally or accidentally to produce cerebral cortical vein
thrombosis and therefore the patients are often not com-
parable. This also implies that randomized studies are not
reliable in those with CVT to arrive at logical conclusions
on therapeutic guidelines and strategies. The set of actions
required to correct the contributory factors will then be
diﬀerent in each patient. Clinical observations based on
case series and sharing of such information alone are
the alternative to arrive at a consensus. Because of the
heterogeneity in the clinical presentation and etiology, the
diagnosis of CVT is often missed, and even if a diagnosis
is made the contributory factors which are often subclinical
are also missed or overlooked. Most often only one of the
etiological factors is prominent enough to be picked up and
it is a universal practice to look for rarer causes and some
inherited causes of venous thrombosis. Diagnosis is often
missed unless clinicians maintain a high index of suspicion
and be aware of the varied clinical presentations to be able to
recognize and manage by prompt and proper application of
clinical skill, rather than depending heavily on investigations
alone for eﬀective management of these patients.
Depending on the site, size, duration, and rapidity of de-
velopment of thrombus, it can present as seizure alone, space
occupying lesion, benign intracranial hypertension, suba-
rachnoid haemorrhage, unexplained altered sensorium, or
meningoencephalitis [2]. It can be mistaken for metabolic
encephalopathy and vertebrobasilar insuﬃciency. Moreover,
thepatientmaylandupwithanypractitionerorspecialistbe-
cause it can coexist with several medical, surgical and ob-
stetric conditions like pregnancy, eclampsia, postoperative2 Thrombosis
phase, uncontrolled diabetes, pyogenic or other meningitis,
DIC, septicemias, hyperviscosity, and thrombophilic states,
collagen vascular disorders, and vasculitic syndromes. It
could also occur while on treatment with certain drugs like
L Asparaginase and Thalidomide. CVT can be the ﬁrst man-
ifestation of a thrombophilic state like polycythemia, throm-
bocytosis (both primary and secondary), leukocytosis, Sickle
cell disease, hyperhomocysteinemia, haemoconcentration
due to a multitude of causes, hypereosinophilia, and APLA
syndromes [2]. As mentioned already almost always more
than one cause coexist in each patient, which are found
out only on good clinical evaluation and not by lab studies
alone. To compound all this the new generation doctors
forget the importance of proper clinical evaluation and cor-
relating important observations in the diet, lifestyle, and
environment of the patients. Many of them do not bother to
ﬁndoutsuchinformationandratherproceedprematurelyto
laboratory investigations to arrive at a diagnosis and they ex-
pect the radiologist to conﬁrm the diagnosis always and
the laboratory alone to ﬁnally pin-down the basic etiol-
ogy of cerebral cortical vein thrombosis. After making a
diagnosis of CVT the clinician should apply clinical skill and
common sense with which it is possible to arrive at one
or more completely correctable common etiological factors
contributing to the development of CVT, even if there is
an underlying inherited disorder which cannot be corrected,
and thus can avoid recurrences in future. Once the diagnosis
of CVT is made it is easily managed if we know all the
contributory factors and almost always has a good prognosis
as compared to other cerebrovascular accidents. It is also
an observation that in many patients with the so called
idiopathic CVT nutritional deﬁciencies and lifestyle issues
are more important basic etiological factors in pathogenesis,
at least in some epidemiological settings as strict vegetarians
and those who consume a unbalanced diet. Research by
observation and studying the patients for their diet, lifestyle
and environment might give the answer to the several
etiological factors in cerebral cortical vein thrombosis, as in
all other clinical problems, rather than depending on the
costly laboratory investigations alone [2].
2. Pathogenesis
The dural sinuses that are most frequently thrombosed are
the superior sagittal sinus, the lateral sinus (transverse sinus
and sigmoid sinus), and cavernous sinus. Less frequently
aﬀected are the straight sinus and the vein of Galen. Still
rarely smaller cortical veins may be the primary site of
thrombus formation without evidence of thrombus in the
majorsinusesorthethrombusinthemajorsinuswouldhave
resolved by the time the patient comes to clinical attention.
This is one reason for the misdiagnosis in CT and MRI.
Occlusion of a venous sinus and/or cortical vein is usually
caused by a partial thrombus or an extrinsic compression
thatsubsequentlyprogressestocompleteocclusion[1].Once
the sinus is occluded, the thrombus may extend to the
cerebral cortical veins draining into that sinus (Figure 1).








Figure 1: The major venous sinuses and their tributaries.
venous infarction, with petechial haemorrhages or overt
hemorrhagic infarction [1]. There are diﬀerent mechanisms
for the signs and symptoms in patients presenting with
cerebral venous thrombosis: (1) local eﬀects caused by
the venous obstruction, consequent ischemia, infarction
or hemorrhage, and the neuronal dysfunction; (2) the
mass eﬀect behaving like an intracranial space occupying
lesion (ICSOL); (3) venous obstruction leading to sudden
development of oedema inside the closed compartment of
the cranial cavity, which varies depending on the size and
site of thrombus, causing rapid development of intracranial
hypertension and its consequences; (4) sudden development
of oedema and ischemia in the cortex corresponding to
the territory involved causing hyper excitability with seizure
discharges and later neuronal dysfunction; (5) symptoms
and signs due to the underlying disorder/disorders respon-
sible for thrombophilic state. In the majority of patients, all
these happen suddenly and simultaneously or sequentially
or one of them dominate in the clinical picture. Unlike
in arterial obstruction, intracranial hypertension, especially
w h e no n eo ft h em a j o rv e n o u ss i n u s e si so b s t r u c t e d ,i sa
very common and early manifestation [2]. Cytotoxic edema
is caused by ischemia, which damages the energy-dependent
cellular membrane pumps, leading to intracellular swelling.
Vasogenic edema is caused by a disruption in the blood-
brain barrier and leakage of blood plasma into the interstitial
spacewhichisreversibleiftheunderlyingconditionistreated
promptly. Besides the severe cerebral oedema of sudden
onset, there is another mechanism for the development
of intracranial hypertension especially when the thrombus
does not resolve or gets organised. Normally, the CSF
is transported from the cerebral ventricles through the
subarachnoid spaces at the base and surface of the brain to
the arachnoid villi, where it is absorbed and drained into
the venous sinuses [2]. Thrombosis of these venous sinuses
leads to impaired absorption of CSF and, consequently,
increased intracranial pressure. Pathological examination
shows enlarged, swollen veins, edema, ischemic neuronal
damage, and petechial hemorrhages, which can merge and
become large hematomas [1, 2].Thrombosis 3
3.CausesandRiskFactors
Why does the thrombus develop? Venous thrombosis any-
where in the body results from exaggerated activity of one
or more mechanisms of haemostasis or reduced activity
of one or more natural antithrombotic mechanisms or a
combination of both [1]. In reality, thrombosis is almost
never due to a single etiological factor, it occurs only when
several etiological factors come together accidentally or inci-
dentally. In normal state the ﬂuidity of blood is maintained
by the following factors: (1) normal intact endothelium;
(2) prostacycline; (3) antithrombin III (4) heparan sulfate;
(5) thrombomodulin; (6) protein C and Protein S; (7)
ﬁbrinolytic System; (8) normal ﬂow of blood; (9) absence
of a prethrombotic/hypercoagulable state (thrombophilic
state). The common conditions with tendency for throm-
bosis (thrombophilic states) to be routinely looked for are
dehydration (even subclinical), unusual postures in travel or
sleep, prolonged immobilisation, surgery or trauma, focus
of infection/inﬂammation/abscess adjacent to the sinuses or
in its drainage areas, pregnancy/postpartum period, hyper-
homocysteinemia, polycythemias, thrombocytosis, obesity,
diabetes, oral contraceptives, hormone replacement thera-
pies, antiphospholipid antibodies, PNH, Behcet’s and other
vasculitis, congestive cardiac failure, nephrotic syndrome,
smoking, Inﬂammation, liver disease (acquired protein C/S,
ATIII def), increasing age, dyslipidemia, atherosclerosis, and
malignancies [1, 2]. Rarely only one of the contributory
causesisanunderlyinghereditarythrombophilia-likeFactor
V Leiden (APCR), prothrombin gene mutation, hereditary
hyperhomocysteinemia, deﬁciency of Protein C, Protein S,
antithrombin deﬁciency, increased factor VIII, and dysﬁb-
rinogenemia.Butinpracticethesehereditarythrombophilias
are not the primary cause in any patient with thrombosis.
One or more of the acquired causes are the real culprit even
when they have an underlying hereditary thrombophilia.
A clinically obvious prothrombotic risk factor or a direct
cause is identiﬁed in about 85 percent of patients with
cerebral venous thrombosis [1–3]. Even in them there
are other several coexisting subclinical factors which need
to be corrected to prevent its recurrence. Most often a
precipitating factor, such as a head injury or obstetrical
delivery, causes cerebral venous thrombosis in a person with
another acquired or genetically increased risk. One example
is hyperhomocysteinemia which is very common due to
poor intake of folic acid containing diet, which is almost
universal and B12 deﬁciency in some strict vegetarians who
do not take a balanced vegetarian diet containing green leafy
vegetables [4]. When such women become pregnant several
other thrombophilic states are added on to the existing ones
and therefore deep vein thrombosis or cerebral cortical vein
thrombosis occurs. Deﬁciency of folic acid, B6, and B12
is the commonest cause of hyperhomocysteinemia rather
than inherited causes of it [4]. Besides that hyperhomocys-
teinemia is seen also in many other conditions like, renal
failure/liver disease, hypothyroidism, smoking, excessive
coﬀee intake, Inﬂammatory bowel diseases, psoriasis, and
rheumatoid arthritis. Similarly, the commonest cause for
Protein C and S deﬁciency is liver disease which often
goes unrecognized, because subclinical liver disease is very
common due to alcohol and the Non-alcoholic fatty liver
disease. Acquired protein S deﬁciency can also be due to
oral contraceptive pills or hormone replacement therapy,
Pregnancy, oral anticoagulants, DIC, nephrotic syndrome,
inﬂammatory conditions, after an acute thromboembolism,
autoantibodies to protein S following varicella, and other
infections. Antithrombin deﬁciency when it is severe can
have severe arterial and venous thrombosis and resistance to
heparin therapy can be there. But after an acute thrombosis,
or while on heparin therapy—ATIII levels are <50%, leading
to wrong diagnosis. Acquired causes of ATIII deﬁciency is
seeninliverdisease,DIC,nephroticsyndrome(lossinurine)
chemotherapy with L Asparaginase and preeclampsia. Ele-
vatedfactorVIIIlevelscanalsocontributetothrombosisand
is seen in increasing age, obesity, pregnancy, surgery, chronic
inﬂammation, liver disease, hyperthyroidism, diabetes, and
in non-O-blood groups [1, 2].
Pregnancy and postpartum period are important con-
siderations in women of childbearing age. Pregnancy itself
is a thrombophilic state due to the changes in blood
like Increased factor VIII, ﬁbrinogen, decreased Protein S,
decreased ﬁbrinolysis (Increased PAI), obesity, caesarean
section, immobilization and other mechanical and haemo-
dynamic factors due to pregnant state [5]. Coexisting hyper-
homocysteinemia is very common due to malnutrition and
consequent deﬁciency of folic acid [4]. Besides the chance
of tissue thromboplastin entering the blood from placenta
due to injury, ischemia, or during delivery of fetus and the
coexisting reactive thrombocytosis due to haemorrhage or
iron deﬁciency state-all contribute to increased thrombotic
tendency. During the last trimester of pregnancy and after
delivery, the risk of cerebral venous sinus thrombosis is
increased. The frequency of peripartum and postpartum
cerebral venous sinus thrombosis is about 12 cases per
100,000 deliveries [5].
Inﬂammatory bowel diseases such as Crohn’s disease and
ulcerative colitis are described as risk factors. Corticosteroids
used in treatment of these conditions may play a causative
role. Collagen vascular diseases such as systemic lupus ery-
thematosus, Wegener granulomatosis, and Behcet syndrome
have been reported to be associated with CVT [1, 2]. Trauma
like head injury, direct injury to the sinuses or the jugu-
lar veins (from jugular catheterization), and neurosurgical
procedures can be triggering the onset of CVT. Lumbar
puncture is postulated to produce CVT sometimes, and
some of the postlumbar puncture headaches could be due to
CVT [1, 2, 6]. A plausible reason is that low CSF pressure
after an LP causes a downward shift of the brain, with
traction on the cortical veins and sinuses. Deformation of
the venous walls by any mechanism may induce thrombosis.
The diagnosis of sinus thrombosis after a lumbar puncture
is diﬃcult, because the headache that follows is attributed
not to sinus thrombosis but to the lumbar puncture itself.
The classical postLP headache typically disappears when the
patient lies down, and resolves within a few days. Headache
in patients with cerebral venous sinus thrombosis does
not change with a shift in posture and it worsens during
the early stages and could be more in early mornings.4 Thrombosis
Infections like otitis and mastoiditis can be complicated by
thrombosis of the adjacent sigmoid and transverse sinuses
[1, 2]. If the contralateral transverse sinus is hypoplastic (a
frequent anatomical variant), absorption of CSF becomes
impaired and hydrocephalus can result (which is formerly
known as otitic hydrocephalus). Spread of infection into
the cerebral venous sinuses may occur by extension from
the paranasal sinuses. These cases also may be associated
with subdural empyema. Bacterial meningitis as a coexistent
conditionshouldbeconsideredinthesecases.Frontalsinuses
are the most common source of infection. A special case
is thrombosis of the cavernous sinuses, which is nearly
always caused by an infection of the paranasal (ethmoid and
sphenoid) sinuses, the orbit, or the face. Multiple organisms
are to be considered, staphylococcus aureus being the most
common. In chronic infections, Gram-negative organisms
and fungi such as Aspergillus species may be found. The
frequency of infectious sinus thrombosis has declined in
adults. Higher frequencies of both systemic infections (e.g.,
neonatal sepsis) and local infections (e.g., otitis) are reported
in children. Though lateral sinus (transverse and sigmoid)
and cavernous sinus thrombosis is usually secondary to
infections in the adjacent areas like otitis media, mastoiditis
and sinusitis, the superior sagittal sinus thrombosis is most
often due to non infective processes. But infection may
reach superior sagittal sinus from the nasal sinuses or as
extension from the lateral or cavernous sinuses or from
epidural or subdural focus of infection. Any of the cerebral
venous sinuses or the cerebral veins which drain into
the sinuses may be occluded partially or completely by
trauma or tumours. The coexisting thrombophilic states like
malnutritionordehydration,hyperhomocysteinemia,andso
forthcanacceleratetheprocessofthrombosis.Thethrombus
can then grow into the sinus or vice versa. Transverse sinus
and sigmoid sinus thrombosis causesheadache and vomiting
with or without fever and features of raised intracranial
pressure. Papilloedema develops which is usually bilateral
(but can be unilateral), drowsiness, coma, and seizures can
occur. Cavernous sinus thrombosis, usually originates from
infections in the orbit, nasal sinuses, or upper half of the
face. The infection commonly involves only one sinus at
the onset but rapidly spreads through the circular sinus to
the other side. One or both of these can be involved by
spread of infection or spread of thrombus from the other
d u r a ls i n u s e s .T h u sc o r t i c a lv e i nt h r o m b o s i so ra n yv e n o u s
or arterial thrombosis is just a manifestation of multiple
thrombophilic states which varies from patient to patient
and a highly individualised approach is essential for eﬀective
management and prevention [1–3, 5–7].
4.ClinicalFeatures
Most common venous sinus to develop thrombosis (or
probably detected commonly) is the superior sagittal sinus
[1, 2, 8]. Irrespective of the sinus aﬀected there are over-
lapping of clinical features except when it is conﬁned to
cavernous sinus or one of the smaller cerebral veins where
there will be distinct focal symptoms and signs depending
on the area aﬀected. Headache is the most frequent but least
speciﬁc symptom; severe headache is present in more than
90 percent of adult patients [2, 6]. Usually the headache
mimics migraine but is persistently unilateral or diﬀuse and
is not relieved after sleep, increases gradually over a couple
of days, but can also start in a split second, mimicking
intracerebral or subarachnoid hemorrhage [6]. Nausea and
vomiting may be associated. CVT can present as isolated
intracranial hypertension syndrome, which is often misdiag-
nosed as benign intracranial hypertension (headache with or
without vomiting, papilledema, and visual problems). Focal
syndrome (focal deﬁcits, seizures, or both) mimicking and
often mistaken for Intracranial space occupying lesion is
not uncommon; even on CT and MRI the venous infarct is
mistaken for glioma or even focal demyelination [1, 2, 4, 9].
Encephalopathywithmultifocalsigns,mentalstatuschanges,
stupor, or coma can occur suddenly over hours or days.
Cerebrallesionsandneurologicsignsdevelopinhalfofthem.
Unilateral hemispheric symptoms such as hemiparesis or
aphasia, followed within days by symptoms due to involve-
ment of the other hemisphere, caused by the development
of cortical lesions on both sides of the superior sagittal sinus
arecharacteristic,butrare.Superiorsagittalsinusthrombosis
may also present as a unilateral lower extremity weakness
or paraplegia [1, 2]. Venous infarct has a higher risk of
haemorrhagic transformation with subarachnoid leak and
maypresentclinicallyasasubarachnoidhaemorrhageaswell
[10].Unlikearterialthrombosisstrictlocalizationtoonevas-
cular territory may be absent often. Cranial nerve syndromes
are seen with lateral venous sinus (sigmoid and transverse
sinus) thrombosis. These include—vestibular neuronopathy,
pulsatile tinnitus, unilateral deafness, double vision, facial
weakness and obscuration of vision. If the thrombosis in
lateral sinus extends to the jugular vein, the patient may
develop involvement of cranial nerves IX, X, XI, and XII due
to Jugular foramen syndrome. If it is secondary to a septic
focus there could be fever and chills and other features of
septicemia. The classic symptoms of lateral sinus thrombosis
are fever, headache, nausea, and vomiting. Seizures occur
in about forty percent, which is focal in 50 percent, but
may generalise to a life-threatening status epilepticus [9].
Thrombosis of the deep venous system (straight sinus and its
branches)causesoftenbilateralthalamiclesions,withbehav-
ioral symptoms such as delirium, amnesia, and mutism,
which can be the only manifestation. If large unilateral
infarcts or hemorrhages compress the diencephalon and
brain stem, patients may become comatose or die from
cerebral herniation [1, 2]. Other causes of coma are diﬀuse
involvement and generalized seizures followed by postictal
coma.Infectiouscavernoussinusthrombosisischaracterized
by headache, fever, and eye symptoms such as periorbital
edema, proptosis, chemosis, and paralysis of eye movements
duetoinvolvementoftheoculomotor,abducent,ortrochlear
nerves. Lateral sinus thrombosis may present with increased
intracranial pressure as the only presenting sign with
associated headache and a pseudotumor cerebri-like picture
[1, 2]. Patients with isolated intracranial hypertension have
headache but no other neurologic symptoms, with the ex-
ception of diplopia due to sixth nerve palsy when theThrombosis 5
intracranial pressure is very high. Fundus examination may
show papilloedema. Severe papilloedema can cause transient
visual impairment, or if it is persistent and left untreated
can cause even permanent blindness. Besides all these the
clinical picture will usually be associated with the underlying
disorder/swhichcontributedtotheprothromboticstate,and
as mentioned before there will always be multiple factors
contributing to that. If the thrombosis occurs in the setting
of meningitis, brain abscess, or uncontrolled diabetes the
clinical picture will be even more confusing. Extension of the
thrombus from the sagittal or lateral sinus into the cerebral
veins is almost always accompanied by dramatic signs and
symptoms due to hemorrhage into the cortical white and
greymatter.Convulsionsoftenarefocal,hemiplegia,aphasia,
or hemianopia can occur [1, 2].
Diagnosis. A high index of suspicion is absolutely essen-
tial to diagnose cerebral venous thrombosis. Diagnosis of
CVT should be considered in all young and middle-aged
patients with recent onset unusual headache, with stroke-
like symptoms, especially with seizures, more so when it
occurs in the absence of the usual risk factors for arterial
thrombosis [1, 2, 5, 6, 9]. Diagnosis is basically clinical, one
should be aware of the varied clinical presentations and if
the clinical picture, is also consistent with CVT—besides
the other usual diﬀerential diagnosis—the next step is to
get a CT or MRI to look for supportive evidence of CVT
and to rule out other mimickers. CT may show multiple
lesions, some haemorrhagic others radiolucent which could
bebilateraloften.Afterrulingoutothercausesfortheclinical
presentation or after getting deﬁnite proof for diagnosis
then start looking for all the contributory factors of CVT.
A common mistake is to depend entirely on the radiologist
to give a deﬁnite diagnosis and on the laboratory to give an
etiological diagnosis always. If the clinical picture is highly
suggestive, is consistent with or at least not against the
diagnosis of CVT and if there is no other deﬁnite etiological
diagnosis on CT or MRI the patient should be managed
as CVT. This is to avoid delay in initiating the speciﬁc
treatment directed at the thrombus and its precipitating
factors. Clinical presentation is highly variable and it is
a notorious mimicker, it may be the presenting clinical
problem or may be developing while under treatment or
observation for another disorder [1–3, 6, 7]. Usually there is
a delay in diagnosis, especially in patients with unexplained
intracranial hypertension, or in those with CT evidence of
hemorrhagic infarcts, especially if the infarcts are multiple
and in those presenting like ICSOL or demyelination on
CT. The clinical suspicion of cortical vein thrombosis based
on sound clinical reasoning is the most important starting
point in the diagnosis and the suspicion of CVT should
be indicated in the request form when referring for CT or
MRI studies. The most sensitive investigation technique to
conﬁrm the diagnosis is MRI in combination with magnetic
resonance venography [8]. T1,a n dT 2-weighted MRI may
show a hyper intense signal from the thrombosed sinuses if
the clot is recently formed. The combination of an abnormal
signal in a venous sinus and a corresponding absence of ﬂow
on magnetic resonance venography conﬁrms the diagnosis
of thrombosis [8]. But it may not be possible to demonstrate
the thrombus in the smaller cortical veins on CT or MRI and
the eﬀects of it in the brain may be mistaken for ICSOL or
demyelination. Thrombus in the major sinus only is picked
up by the imaging studies and we cannot expect it to be
present at the site when we order for the imaging, it could
be resolving or even completely resolved by the time the
imaging is done. CT scanning is a useful technique for the
initial evaluation basically to rule out other acute cerebral
disorders that mimic CVT and occasionally to show lesions
which suggest venous infarcts or hemorrhages. Many times
CT scan is reported as normal in patients with CVT. Empty
delta sign on CECT—that is, enhancement of the collateral
veins in the superior sagittal sinus walls surrounding a
nonenhanced thrombus in the sinus is suggestive [2, 8].
Dense triangle sign is formed by fresh coagulated blood in
the superior sagittal sinus. HRCT may show the thrombus
as a hyperintense signal in a sinus or even in the cortical
veins (the “cord sign”). CT venography is a promising
new technique for creating images of the cerebral venous
system [8]. If the diagnosis is still uncertain after MRI
or CT venography, cerebral angiography may be indicated.
Angiography provides better details of the cerebral veins and
hence is useful in the diagnosis of rare cases of isolated
thrombosis of the cortical veins without sinus thrombosis.
Angiography also shows dilated and tortuous (“corkscrew”)
veins, which are evidence of thrombosis downstream in the
sinuses [8]. But depending too much on radiological studies
alone for making the diagnosis will result in wrong diagnosis
sometimes. The posterior ischemic leukoencephalopathy
reported by the radiologists appears to be one such instance
because on clinical evaluation these patients have all the
features of CVT involving the posterior circulation and they
also have the clinical setting to develop venous thrombosis.
But if the clinical diagnosis is not asserted by the referring
clinician, when there is no radiologic proof of the thrombus
in the lateral sinus, it is reported as posterior ischemic
leukoencephalopathy. This inference is made by observing
the clinical features, the clinical setting, and the course and
the predisposing conditions in these patients. It is very likely
that we fail to demonstrate the thrombus on investigation
and this could be explained by dissolution of the thrombus
by natural mechanisms by the time MRI is taken and the
evidence of the original insult to brain is still persisting on
radiological studies. It could also be that demonstration of
thrombus in transverse or sigmoid sinus could be diﬃcult.
In the clinical evaluation, what usually helps to diagnose
CVT is the dramatic onset to suggest a CVA and the lack of
speciﬁc localization to a speciﬁc arterial territory, clinically
or by radiological methods. During evaluation one should
take a detailed history to look for any of the clinical settings
for an increased risk of venous thrombosis, like history of
decreased ﬂuid intake, or increased ﬂuid loss like excessive
sweating, diarrhea or vomiting, drug intake including OCP,
travel, injury, constitutional symptoms, fever, weight loss,
chemotherapy with L Asparaginase or thalidomide, and
so forth. A detailed dietary history for any features to
suggest B12 or folic acid deﬁciency is absolutely essential.6 Thrombosis
Look also for physical signs of B12 deﬁciency (like knuckle
hyperpigmentation, premature graying of hair, neurological
ﬁndings), signs of polycythemia (congested conjunctiva,
ruddy complexion, palmar erythema), liver disease nonal-
coholic disorder or any ﬁndings to suggest malignancy.
4.1. Diagnostic Approach. It should be individualized de-
pending on the clinical setting.
4.1.1. How to Recognize CVT?
(1) Sudden onset of headache, seizure or neurologic def-
icit which is diﬃcult to be attributed to one vascular
territory, or unexplained vascular headache, which is
persistently unilateral or sometimes diﬀuse.
(2) CT is reported as normal/or reported as ICSOL/glio-
ma/infarct/haemorrhage not conﬁned to any speciﬁc
vascular territory.
(3) No other diagnosis/or confusion in diagnosis or re-
ported as posterior ischemic leukoencephalopathy
/demyelinating plaque.
(4) Risk factors or clinical setting to develop venous
thrombosis.
If all the above four are present it is almost always CVT
(unless otherwise proved beyond doubt by evaluation,
investigation and follow up) and hence it is wiser to be
managed as CVT. Once CVT is suspected MR and MR
venogram usually helps to conﬁrm but diﬃcult to rule out
till another diagnosis is established with certainty.
The Diagnostic steps should involve the following.
(1) Recognize—CVT by applying, good clinical skill and
ahighindexofsuspicion,mostimportantstepisthis.
(2) Rule out other possible diagnosis—by supporting
investigations like CT and MRI, or sometimes only
MR/MR venogram helps to rule in CVT.
(3) Clinical evaluation to assess risk factors of throm-
bophilia by history and physical examination and
supporting lab tests—even when there is no con-
ﬁrmed thrombus in one of the venous sinuses.
(4) Identify all the possible acquired causes—investigate
when necessary, if CVT is a the cause or strong pos-
sibility.
(5) Lookalsoforpossiblehereditarycauses—ifidentiﬁed
or strongly suspected consider prolonged anticoagu-
lation and avoidance of all acquired risk factors for
thrombosis.
One can suspect hereditary causes of thrombophilia in the
following settings: absence of acquired causes, documented
venous thrombo embolism in ﬁrst degree relatives, early age
ofonset(<45years),spontaneousandunprovokedthrombo-
sis, recurrent episodes of venous thromboembolism, throm-
bus in unusual locations, thrombosis on OCP, recurrent fetal
loss [1, 2, 6].
Lab Studies. After making the diagnosis of CVT, lab studies
are necessary to look for the various contributory factors
for the prothrombotic state. Complete blood count and ESR
might give evidence of polycythemia (high Hb, PCV, and low
ESR), B12 deﬁciency (low Hb, cytopenia, high MCV), very
highESRmightfavouracollagenvasculardisorder.ANAand
Anti-Ds DNA are important in suspected collagen vascular
disorder. Antiphospholipid and anticardiolipin antibodies
are to be done when primary or secondary APLA syndrome
is suspected. Elevated SGPT and serum protein may help to
screen for liver disease. Decreased albumin: globulin ratio,
with hyper gammaglobulinemia can suggest hyper viscosity
states. Sickle cell preparation or hemoglobin electrophoresis
may be required in relevant cases. Urine protein to screen
for nephrotic syndrome, D-dimer values may be beneﬁcial
in screening patients for venous thrombosis. Evaluation for
protein S, C, antithrombin III, lupus anticoagulant, and fac-
tor V Leiden mutation should not be made while the patient
is on anticoagulant therapy, and as such these disorders are
rare as compared to several other acquired disorders which
are easily managed. Lumbar puncture is helpful in evaluating
for meningitis as an associated infectious process if there
is clinical evidence of it. A large unilateral hemispheric
lesion or posterior fossa lesion demonstrated on CT scan or
MRI is a contraindication for lumbar puncture. In the past,
compression of the jugular vein unilaterally with pressure
measurement has been utilized which adds little to the
diagnosis, and is usually not performed. EEG may be helpful
in evaluating a seizure focus, may be normal, may show
mild generalized slowing, or show focal abnormalities if a
unilateral infarct occurs, but it does not genuinely inﬂuence
diagnosis and management [1–3, 5, 6, 9, 10].
4.2. Mortality/Morbidity. A mortality rate of 10–80% has
been reported although the higher rate is based on older
data. Recent studies estimate a morbidity range of 6–20%,
including residual focal neurologic deﬁcits and blindness
secondarytoopticnerveatrophy.Theprognosisforreturnof
function is believed to be somewhat better than for arterial
stroke. Most often the prognosis is excellent especially
when the underlying disorders are promptly recognized and
corrected [3, 7].
5. Management and Outcome
If promptly diagnosed and all the contributory factors are
identiﬁed and corrected, most often it is easily managed
and the patients have an excellent outcome as compared to
other cerebrovascular accidents. Correct all the identiﬁable
and reversible acquired thrombophilic states. Give intra-
venous ﬂuids for dehydration, venesection in polycythemia;
B12, folic acid and pyridoxine in hyperhomocysteinemia;
antiplatelet drugs and drugs for reducing platelet count in
extreme thrombocytosis by using Hydroxyurea, aspirin and
steroidinAPLAsyndrome,steroidandimmunosuppressants
in SLE or other vasculitis disorders, antibiotic and antifungal
agents in suspected infective thrombosis. Heparin is given
in small doses as unfractionated heparin 2500units toThrombosis 7
5000unitss/c bid even when there is some haemorrhagic
transformation. Higher doses can be considered if there is no
haemorrhagic transformation. Dexamethasone may be used
to reduce the severe intracranial pressure, unless there is a
deﬁnite contraindication for using it. Mannitol can be used
along with dexamethasone to reduce intracranial tension
rapidly. The combination of acutely increased intracranial
pressure and large venous infarcts is dangerous, and patients
candiewithinhoursfromcerebralherniation.Impairedcon-
sciousness and cerebral hemorrhage are associated with a
poor outcome, but in practice even patients with these man-
ifestations can make a remarkable recovery, if treated
promptly by an early clinical diagnosis. Head should be kept
elevated to 30–40 degrees and supplemental oxygen may be
given if level of consciousness is decreased. Seizures should
be treated with appropriate anticonvulsants. The priority
of treatment in the acute phase is to stabilize the patient’s
condition and to prevent or reverse cerebral herniation [1, 2,
5, 6, 9, 10].
5.1. The Issue of Anticoagulation [11–13]. The most impor-
tant treatment option is anticoagulation with heparin to
arrest the thrombotic process and to prevent pulmonary
embolism, which may complicate venous sinus thrombo-
sis. Anticoagulant treatment has raised much controversy
because of the tendency of venous infarcts to become
hemorrhagic: about 40 percent of all patients with sinus
thrombosis have a hemorrhagic infarct even before anticoag-
ulant treatment is started. The main reason to avoid heparin
has been concern about its safety. But clinical trials show
no increased or new cerebral hemorrhages developing after
treatmentwith heparin. Most physicians now start treatment
with heparin as soon as the diagnosis is conﬁrmed, even
in the presence of hemorrhagic infarcts. No studies have
compared the eﬀect of fractionated heparin with that of un
fractionated heparin. Conventional unfractionated heparin
is enough for all practical purposes. After three to four days
of heparin therapy or after the patient has shown steady
improvement, warfarin is started at minimally eﬀective
doses, both are overlapped for two days and then heparin is
withdrawn. But the optimal duration of oral anticoagulant
after the acute phase is decided by the individual patient
proﬁle. Usually oral anticoagulants are given for six months
after a ﬁrst episode of venous sinus thrombosis, or longer
when there is persistence of the predisposing factors.
5.2. Thrombolysis [11]. Endovascular thrombolysis can be
attempted with the administration of a thrombolytic
enzyme, usually urokinase, into the sinus, sometimes in
combination with mechanical thromboaspiration. Published
reports are limited to case reports and uncontrolled studies,
fromwhichitisnotpossibletoconcludethattheresultsasso-
ciated with endovascular thrombolysis are superior to those
with systemic heparin. Until better evidence is available,
endovascular thrombolysis may be applied at centers where
the staﬀ have experience in interventional radiology, and this
treatmentmethodshouldberestrictedonlytopatientswitha
poor prognosis [14]. A randomized trial is probably needed
to compare the eﬀect of heparin with that of endovascular
thrombolysis in selected high-risk patients. In cases of severe
neurological deterioration, open thrombectomy and local
thrombolytic therapy have been described as beneﬁcial [11–
13, 15, 16].
Surgical Care. In cases of severe neurological deterioration,
open thrombectomy and local thrombolytic therapy have
been described as beneﬁcial in patients with subdural em-
pyema or brain abscess.
5.3. Persistent Intracranial Hypertension. In patients who
have symptoms of chronic intracranial hypertension only,
theﬁrstpriorityistoruleoutanintracranialspaceoccupying
lesion and to see whether venous sinus thrombosis could be
the cause for it. If there are no contraindications, such as
largeinfarctsorhemorrhages,alumbarpunctureisthenper-
formed to measure the cerebrospinal ﬂuid pressure and also
as a therapeutic measure. Oral acetazolamide may re-duce
the intracranial pressure, which may be continued for weeks
to months, as is practiced in patients with idiopathic in-
tracranial hypertension. If repeated lumbar punctures and
treatment with acetazolamide do not control the intracranial
pressure within about two weeks, surgical drainage of the
CSF is indicated, usually by a lumboperitoneal shunt [15,
16].
6. Summary
More and more cases of cerebral venous thrombosis are now
being diagnosed and important advances have been made
in our understanding of the pathophysiology of it. Even
then cerebral venous sinus thrombosis remains a diagnostic
challenge and is a potentially lethal disease. High index of
suspicion and awareness of the clinical features and the pre-
disposing factors helps in diagnosis as illustrated by the two
case histories below. With improved diagnosis and prompt
treatment it is possible to achieve an excellent outcome for
most patients. An acquired prothrombotic risk factor or a
thrombophilic state can be identiﬁed in most patients with
sinus thrombosis. Often, one obvious precipitating factor,
such as pregnancy, delivery or postpartum state, or head
injury or trauma causes sinus thrombosis in a person with
one or more acquired and often subclinical thrombophilic
sates or rarely with a genetically increased risk. During the
last trimester of pregnancy and after delivery, the risk of
venous sinus thrombosis is increased many times [3–5].
Case History 1. Thirty year old mechanic came with sudden
onset of head ache of four days duration, the headache
was more on the left side. This was associated with several
episodes of vomiting. No history of seizures, altered sen-
sorium, loss of consciousness, weakness, bowel or bladder
symptoms, neck pain, visual blurring. There was no head in-
jury/trauma/ear discharge/fever, cough, breathlessness, chest
pain. He was a strict vegetarian and did not consume ad-
equate green leafy vegetables and fruits. He had left leg swell-
ing two years back diagnosed as deep vein thrombosis. Was8 Thrombosis
Figure 2: MRI scans showing cortical venous thrombosis.
Figure 3: MRI scans showing cortical venous thrombosis.
on Warfarin for several months which was stopped only
two months back. There was no history of hypertension,
Diabetes, Ischemic heart disease or similar illness in the past.
He did not smoke or drink alcohol and did not have any
addictions. From the history a diagnosis of cerebral vein
thrombosis/sub arachnoid hemorrhage or vascular headache
were considered. On examination he was conscious, ori-
ented,cooperative,withaBMIof22,pulserateof64/min,BP
140/90. No pallor/jaundice/cyanosis/clubbing/LNE/edema.
Skin showed Knuckle hyper pigmentation and premature
graying of hair suggesting B12 deﬁciency [4]. Abdomen,
cardiovascular system and respiratory system were normal.
Pupils were equal and reacting, No cranial nerve palsy, No
motor/sensory involvement, No neck stiﬀness, No cerebellar
signs, Skull and spine normal, Fundus-No evidence of papil-
loedema. On Investigations, Hb 11.6g/dL, TLC 12000/mm3,
DLC P 71 L 21 E 8, MCV 97.2ﬂ, MCH 32.3, MCHC 33.2,
RDW 16.1%, Platelet count was 2,78000/mm3,E S R1 5m m
inﬁrsthour.CTheadwasnormal,sincetheclinicaldiagnosis
wasCVTproceededwithMRIandMRvenogramwhichcon-
ﬁrmed the diagnosis of Sagittal sinus thrombosis (Figures 1
and 2). Serum homocysteine was elevated 16.61micromol/L
(normal 5–15 micromol), all other investigations including
screening for collagen vascular disease, APLA, and vasculitis
did not yield any positive results. The ﬁnal diagnosis was
cortical vein thrombosis due to hyperhomocysteinemia of
Vit B12 deﬁciency. He was treated with Inj heparin 5000iuiv
Q6h, Inj Mannitol, Inj. vitamin B12, Inj Dexamethasone,
later warfarin was added and titrated according to INR. Folic
acid and multivitamin tablets were given from day one.
The case history illustrates that if CVT was not suspected
by history the diagnosis could be missed, and if a detailed
history of diet and lifestyle is not asked for, B12 deﬁciency
could have been missed.
Case History 2 [4]. Twenty year old female who was
asymptomatic till four months back, went to her doctor
with recurrent episodes of persistently left sided headache
of four months duration, subsiding with analgesics. It was
not associated with any sensory or motor complaints and
therewasnohistoryofearlymorningheadache.Twomonths
after the onset of headache she developed generalised tonic-
clonic seizures, while watching television. CT head showed
isodensetohypodensenon-enhancinglesionwithperipheral
hypodense zone in the upper posterior part of the left
temporal lobe and adjacent parietal lobe with minimal
mass eﬀect (Figure 3). A diﬀerential diagnosis of low grade
glioma/granuloma/focal infarction/resolving hematoma was
considered. MRI showed hypodense lesion in T1 weighted
images and hyperdense lesion in T2 weighted images in
left temporal lobe which supported the diagnosis of low
grade glioma (Figures 4 and 5). Then patient was referred
form the local hospital for surgery to another higher centre.
Prior to surgery at the higher centre she underwent a repeat
MRI which showed focal gyral hyperintensity in the region
of left posterior temporal gyrus on T1 weighted images.
Corresponding areas showed signal intensiﬁcation on T2
weighted images. Hyperintensity was noted also along the
course of vein of Labbe in F1 3D images suggesting vein
of Labbe thrombosis (Figure 6). MR venogram subsequently
conﬁrmed the cortical vein thrombosis.
She was further evaluated at the higher centre, the
physical examination was unremarkable according to them
except for the pallor. The Hb was 9.2gm/dL, with macro-
cytosis (MCV110ﬂ), MCH 33.8 and MCHC 36, TLC and
DLC was normal with mild thrombocytosis (5.1lakh/cmm)
RDW of 18%, with a normal ESR and reticulocyte count
(0.6). ANA, Anti-DS DNA, Anti-phospholipid antibody
were negative. The CSF study showed opening pressure
of 110 mmof CSF with total of 2cells/cmm which were
lymphocytes and the protein was 41mg/dL with sugar of
70mg/dL (corresponding blood sugar of 99mg/dL). The
ECG and chest skiagram were normal as well as the 2D
echocardiogram. Sleep EEG showed mild degree of focal
nonspeciﬁc electrophysiological abnormalities over the left
posterior temporal region. No epileptiform abnormalities
seen. The striking abnormality was the serum homocysteine
of 65 micro mol/L (normal 5–15 micromol/l). She was
treated with antiepileptics and was supplemented with folate
for the macrocytic anemia and for hyperhomocysteinemia.
Vitamin B12 was not supplemented adequately from that
centre. She was referred to us for evaluation of anemia and
the pro-coagulant state.
A detailed review of history showed that she was on
a strict vegetarian diet with no consumption of egg or
dairy products. The vegetarian diet she took was erratic
and totally unbalanced without adequate intake green leafy
vegetables. She was moderately built and nourished withThrombosis 9
(a) (b)
Figure 4: Plain CT scan showing hypodense lesion mistaken for glioma (actually venous infarct).
 
(a) (b)
Figure 5: Hyperdense lesion in T2 weighted MRI scan suggesting glioma.
(a) (b)
Figure 6: MRI scan showing hyperintensity along the course of vein of Labbe.10 Thrombosis
mild pallor, and striking premature greying of the hair
and knuckle hyper-pigmentation. She had by then features
suggestiveofmildSubacutecombineddegenerationofspinal
cord as evidenced by Romberg’s sign positivity. Folate
supplementation alone which she received prior to coming
to our centre, in the presence of severe Vitamin B12
deﬁciency might have precipitated the neurological signs.
ThusaclinicaldiagnosisofvitaminB12deﬁciencywasmade.
The following investigation were done: Peripheral smear
showed moderate anisopoikilocytosis with normochromic
normocytic cells, macroovalocytes, tear drop cells and a
few microcytes suggestive of dimorphic anemia. Serum
vitamin B12 was 293pg/mL (211–911pg/mL) and the serum
ferritin was decreased. Peripheral smear report and lower
limit of vitamin B12 in spite of partial supplementation
earlier, supported the diagnosis of vitamin B12 deﬁciency
with iron deﬁciency. Hyperhomocysteinemia was secondary
to B12 deﬁciency which resulted in hypercoagulable state.
Patient was treated with vitamin B12 and folate and she
improved dramatically over the next few weeks. Currently
she is asymptomatic and is adhering to balanced diet and is
not on anticoagulants for the last two years. Thanks to the
preoperative diagnosis of cortical venous thrombosis by the
good radiologist which saved her and her family from the
agony of an unwanted surgery and its complications.
This case history illustrates that if we do not elicit the
dietary history and if we fail to notice the physical signs
of B12 deﬁciency it will prolong the agony even after the
diagnosis of CVT is made. It also tells that the thrombus
may not be demonstrable in major sinuses at the time
of evaluation. Therefore, clinical suspicion, proper clinical
evaluation, supporting investigations, and clinical judgment
should be the most important in arriving at the conclusions.
6.1. Atherothrombotic Properties of Homocysteine. Hyper-
homocysteinemia can lead to vascular events like acute
coronary syndromes, recurrent coronary events, stroke and
venous thrombosis. It can be familial or acquired due to
vitamin deﬁciencies. Homocysteine has primary atherogenic
and prothrombotic properties. Histopathologic hallmarks
of homocysteine-induced vascular injury include intimal
thickening, elastic lamina disruption, smooth muscle hyper-
trophy, marked platelet accumulation, and the formation
of platelet-enriched occlusive thrombi. Homocysteine pro-
motes leukocyte recruitment by upregulating monocyte
chemoattractant protein-1 and interleukin-8 expression and
secretion. The thiolactone metabolite of homocysteine can
combine with LDL-cholesterol to produce aggregates that
are taken up by vascular macrophages in the arterial intima;
these foam cells may then release the lipid into atheroscle-
rotic plaques. Homocysteine increases smooth muscle cell
proliferation and enhances collagen production. Prothrom-
botic eﬀects of homocysteine, which have been demon-
strated in patients with acute coronary syndromes include
attenuation of endothelial cell tissue plasminogen activator
binding sites, activation of factor VIIa and V, inhibition
of protein C and heparan sulfate, increased ﬁbrinopeptide
A and prothrombin fragments 1 and 2, increased blood
viscosity, and decreased endothelial antithrombotic activity
due to changes in thrombomodulin function. Oxidative
stressbyfreeradicalsformedduringtheoxidationofreduced
homocysteine may directly injure endothelial cells. Marked
platelet accumulation may be secondary to direct proag-
gregatory eﬀects of homocysteine or to an impairment in
endothelium-mediated platelet inhibition. Prolonged expo-
sure of endothelial cells to homocysteine reduces the activity
of dimethylarginine dimethylaminohydrolase, the enzyme
that degrades asymmetric dimethylarginine, an endogenous
inhibitor of nitric oxide synthase; this impairs the pro-
duction of nitric oxide. This may contribute to impaired
endothelium-dependent vasodilation of both conduit and
resistance vessels [1, 4].
Vitamin B12, folate and pyridoxine deﬁciency con-
tributes to development of hyperhomocysteinemia. Ran-
domised control trials support treating all hyperhomo-
cysteinemic patients with venous thrombosis with folic
acid (1mg/day), vitamin B6 (10mg/day), and vitamin B12
(0.4mg/day).AllpatientsshouldreceiveaBcomplexvitamin
to mitigate against peripheral neuropathy. Normalization of
the homocysteine concentration has been reported within
two weeks, but further lowering of homocysteine levels
occurs by six weeks. Above all the importance of adherence
to a balanced diet should be stressed to all patients to prevent
life threatening thrombotic events. It can be postulated that
folic acid and Iron deﬁciency with hyperhomocysteinemia
andthrombocytosisinthealreadyprothormboticstatecould
be the causes in many patients who develop post partum
cortical vein thrombosis [4].
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